Professor, Medicine, University of California Los Angeles David Geffen SOM
Hematology
Dr. Rowan T. Chlebowski, MD
Rowan Chlebowski works in the field of Hematology. He went to Case Western Reserve University School of Medicine. He received 5 awards: "America's Top Doctors", "Top Doctors:LA Area", "America's Top Doctors for Cancer", "Top Doctors:Southern California" and "Redbook Magazine: Top Breast Cancer Doctors". Rowan T. Chlebowski is a published doctor and has 41 publications published. The lastest was: 'Physical Functioning among Women 80 Years of Age and Older With and Without a Cancer History.' Rowan Chlebowski accepts Medicare payments and is listed with Medicare.gov.
Publications
- Performance of the Breast Cancer Risk Assessment Tool Among Women Age 75 Years and Older.
- Continuous Combined Estrogen Plus Progestin and Endometrial Cancer: The Women's Health Initiative Randomized Trial.
- Physical Functioning among Women 80 Years of Age and Older With and Without a Cancer History.
- SNPs and breast Cancer risk prediction for African American and Hispanic women.
- Association Between Obesity and Postmenopausal Breast Cancer Risk-Reply.
- Statins and breast Cancer stage and mortality in the Women's Health Initiative.
- Aromatase inhibitors, tamoxifen, and endometrial Cancer in breast Cancer survivors.
- Breast Cancer and Menopausal Hormone Therapy by Race/Ethnicity and Body Mass Index.
- Risk of breast, endometrial, coloRectal, and renal cancers in postmenopausal women in association with a body shape index and other anthropometric measures.
- Oral Bisphosphonate Use and Risk of Postmenopausal Endometrial Cancer.
- Relationships between dog ownership and physical activity in postmenopausal women.
- Cancer Incidence and Mortality during the Intervention and Postintervention Periods of the Women's Health Initiative Dietary Modification Trial.
- Birth weight and subsequent risk of Cancer.
- American Society of Clinical Oncology Position Statement on Obesity and Cancer.
- Active and passive smoking in relation to lung Cancer incidence in the Women's Health Initiative Observational Study prospective cohort.
- Association between diabetes, diabetes treatment and risk of developing endometrial Cancer.
- Reply to P. Niravath et al.
- Menopausal hormone therapy and Cancer: Changing clinical observations of target site specificity.
- Adherence to endocrine therapy in breast Cancer adjuvant and prevention settings.
- Body mass index, physical activity, and mortality in women diagnosed with ovarian Cancer: Results from the Women's Health Initiative.
- Quality of Life in MAP.3 (Mammary Prevention 3): A Randomized, Placebo-Controlled Trial Evaluating Exemestane for Prevention of Breast Cancer.
- Dietary Cadmium Exposure and Risk of Breast, Endometrial, and Ovarian Cancer in the Women's Health Initiative.
- Calcium Plus Vitamin D Supplementation and Health Outcomes Five Years After Active Intervention Ended: The Women's Health Initiative.
- Investigating the Association of Lactation History and Postmenopausal Breast Cancer Risk in the Women's Health Initiative.
- Multivitamin and mineral use and breast Cancer mortality in older women with invasive breast Cancer in the women's health initiative.
- Vitamin D intake and lung Cancer risk in the Women's Health Initiative.
- Diabetes, metformin use, and coloRectal cancer survival in postmenopausal women.
- Sex Hormone Levels and Risk of Breast Cancer With Estrogen Plus Progestin.
- Menopausal Hormone Therapy and Health Outcomes During the Intervention and Extended Poststopping Phases of the Women's Health Initiative Randomized Trials.
- Oral bisphosphonate use and coloRectal cancer incidence in the Women's Health Initiative.
- Severity of comorbid conditions and early-stage breast Cancer therapy: linked SEER-Medicare data from 1993 to 2005.
- Nutrition and physical activity influence on breast Cancer incidence and outcome.
- Adjuvant Aromatase Inhibitor Options in Overweight and Obese Postmenopausal Women with Breast Cancer.
- Walking speed, physical activity, and breast Cancer in postmenopausal women.
- Estrogen Plus Progestin and Breast Cancer Incidence and Mortality in the Women's Health Initiative Observational Study.
- Vitamin d and breast Cancer incidence and outcome.
- Breast Cancer after use of estrogen plus progestin in postmenopausal women.
- Metformin and breast and gynecological Cancer risk among women with diabetes.
- Hormone therapy use and outcomes in the Women's Health Initiative trials--reply.
- Association between Sleep and Breast Cancer Incidence among Postmenopausal Women in the Women's Health Initiative.
Schools
Case Western Reserve University School of Medicine
L a Co Usc Med Center
Metrohealth Med Center
Conditions Treated
- Acute Leukemia
- Anal and Rectal Cancer
- Anemia
- Bile Duct Cancer
- View All
Doctors Specialties
- Medical Oncology
- Oncology
- Hematology
Accepted Insurances
Awards
- America's Top Doctors
- Top Doctors:LA Area
- America's Top Doctors for Cancer
- Top Doctors:Southern California
- Redbook Magazine: Top Breast Cancer Doctors
Education
-
University of Southern California - LAC+USC Medical Center
-
Case Western Reserve University - MetroHealth
-
Case Western Reserve University School of Medicine
Hospital
-
Ronald Reagan UCLA Medical Center
-
Harbor-UCLA Medical Center
Drug Facts
| NPI NUMBER |
|
1902876386 |
| NPPES Provider LastName |
|
CHLEBOWSKI |
| NPPES Provider FirstName |
|
ROWAN |
| NPPES Provider ZIPCode |
|
905022047 |
| NPPES Provider State |
|
CA |
| Specialty Description |
|
Hematology/Oncology |
| Total Claim Count |
|
26.0 |
| Distinct Opioid Count |
|
0.0 |
| Opioid Claim Count |
|
0.0 |
| Percent Opioid Claims |
|
0.0 |
Helpful Reviews
Give
Anonymous Review
Medicare Facts
| National Provider Identifier [NPI] |
1902876386 |
| Last Name Of The Provider |
CHLEBOWSKI |
| First Name Of The Provider |
ROWAN |
| View All |
|
Similar Doctors
Doctor Directory | TOS | twitter | FB | Angel | blog
This Doctor is OpenDoctor Recommended.
